Ann Stanesa co-founded Ten Bridge Communications after nearly 20 years in leadership positions focused on communications and marketing in biotech and pharma. Most recently, Ann led the rapid growth of Feinstein Kean Healthcare's biotech practice, focusing on brand development and ecosystem engagement strategies for dozens of successful emerging biotechnology companies. Previously Ann spent 10 years at Genzyme Corporation, serving as director of public affairs responsible for Genzyme's visibility, relationships, and reputation throughout the community. She directed the thought leadership strategy for senior executives, and created and managed high-profile crisis management strategies and other corporate programs. Ann's experience at Genzyme also included managing the global medical education program for the renal business unit, directing the key opinion leader program, and overseeing relationships with key external patient associations. Prior to joining Genzyme, Ann worked at Searle Pharmaceuticals on direct-to-consumer marketing and non-branded programs for patients with arthritis, and at Pricewaterhouse Coopers in the marketing department for the U.S. healthcare practice and Boston office. Ann started her career in the Massachusetts legislature as an aide to a senator.